ArticleFrontiers in pharmacology2023

Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy.

P Smyth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.